ATA218980A - Verfahren zur herstellung von neuen piperazinochinazolinderivaten und deren saeureadditionssalzen - Google Patents

Verfahren zur herstellung von neuen piperazinochinazolinderivaten und deren saeureadditionssalzen

Info

Publication number
ATA218980A
ATA218980A AT0218980A AT218980A ATA218980A AT A218980 A ATA218980 A AT A218980A AT 0218980 A AT0218980 A AT 0218980A AT 218980 A AT218980 A AT 218980A AT A218980 A ATA218980 A AT A218980A
Authority
AT
Austria
Prior art keywords
ochinazoline
derivatives
acid addition
addition salts
producing new
Prior art date
Application number
AT0218980A
Other languages
English (en)
Other versions
AT373596B (de
Inventor
Simon Fraser Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10504770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA218980(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of ATA218980A publication Critical patent/ATA218980A/de
Application granted granted Critical
Publication of AT373596B publication Critical patent/AT373596B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT0218980A 1979-04-25 1980-04-23 Verfahren zur herstellung von neuen piperazinochinazolinderivaten und deren saeureadditionssalzen AT373596B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914431 1979-04-25

Publications (2)

Publication Number Publication Date
ATA218980A true ATA218980A (de) 1983-06-15
AT373596B AT373596B (de) 1984-02-10

Family

ID=10504770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0218980A AT373596B (de) 1979-04-25 1980-04-23 Verfahren zur herstellung von neuen piperazinochinazolinderivaten und deren saeureadditionssalzen

Country Status (33)

Country Link
US (1) US4279910A (de)
JP (1) JPS55145684A (de)
KR (1) KR830002567B1 (de)
AR (1) AR224400A1 (de)
AT (1) AT373596B (de)
BE (1) BE882967A (de)
CA (1) CA1132558A (de)
CH (1) CH642076A5 (de)
CS (1) CS209950B2 (de)
DD (1) DD150202A5 (de)
DE (1) DE3015676A1 (de)
DK (1) DK121080A (de)
EG (1) EG14651A (de)
ES (1) ES8101588A1 (de)
FI (1) FI64592C (de)
FR (1) FR2455042A1 (de)
GB (1) GB2049683B (de)
GR (1) GR68049B (de)
HU (1) HU184747B (de)
IE (1) IE49705B1 (de)
IL (1) IL59900A (de)
IT (1) IT1141490B (de)
LU (1) LU82394A1 (de)
NL (1) NL182563C (de)
NO (1) NO152508C (de)
NZ (1) NZ193511A (de)
PH (1) PH15156A (de)
PL (1) PL121470B1 (de)
PT (1) PT71139A (de)
SE (1) SE435061B (de)
SU (1) SU915804A3 (de)
YU (1) YU41709B (de)
ZA (1) ZA802488B (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
GB2049683A (en) 1980-12-31
CH642076A5 (de) 1984-03-30
CS209950B2 (en) 1981-12-31
YU41709B (en) 1987-12-31
IE800827L (en) 1980-10-25
FR2455042A1 (fr) 1980-11-21
AT373596B (de) 1984-02-10
DK121080A (da) 1980-10-26
NO152508B (no) 1985-07-01
KR830002567B1 (ko) 1983-11-14
NO801196L (no) 1980-10-27
JPS55145684A (en) 1980-11-13
YU113180A (en) 1983-02-28
FI64592B (fi) 1983-08-31
IE49705B1 (en) 1985-11-27
NL182563B (nl) 1987-11-02
PT71139A (en) 1980-05-01
GR68049B (de) 1981-10-29
PL121470B1 (en) 1982-05-31
IL59900A (en) 1983-11-30
SU915804A3 (en) 1982-03-23
FI801306A (fi) 1980-10-26
FR2455042B1 (de) 1983-05-20
NZ193511A (en) 1982-03-30
NL182563C (nl) 1988-04-05
AR224400A1 (es) 1981-11-30
NO152508C (no) 1985-10-09
FI64592C (fi) 1983-12-12
IL59900A0 (en) 1980-06-30
SE435061B (sv) 1984-09-03
IT1141490B (it) 1986-10-01
JPS5738591B2 (de) 1982-08-16
CA1132558A (en) 1982-09-28
LU82394A1 (fr) 1980-07-31
PL223755A1 (de) 1981-02-13
NL8002387A (nl) 1980-10-28
DE3015676A1 (de) 1980-11-13
HU184747B (en) 1984-10-29
ES490867A0 (es) 1980-12-16
GB2049683B (en) 1983-01-26
PH15156A (en) 1982-08-24
DD150202A5 (de) 1981-08-19
ES8101588A1 (es) 1980-12-16
ZA802488B (en) 1981-08-26
US4279910A (en) 1981-07-21
EG14651A (en) 1985-03-31
IT8021598A0 (it) 1980-04-23
SE8003122L (sv) 1980-10-26
KR830002758A (ko) 1983-06-30
BE882967A (fr) 1980-10-24

Similar Documents

Publication Publication Date Title
AT375366B (de) Verfahren zur herstellung von neuen indolderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
ATA276978A (de) Verfahren zur herstellung von neuen guanidin- derivaten und von deren saeureadditionssalzen
AT373589B (de) Verfahren zur herstellung von neuen 5h-2,3benzodiazepin-derivaten und deren saeureadditions- salzen
AT363090B (de) Verfahren zur herstellung von neuen piperazinderivaten und deren salzen
AT373880B (de) Verfahren zur herstellung von neuen imidazolderivaten und von deren salzen
AT374188B (de) Verfahren zur herstellung von neuen a-alkylimidazolderivaten und deren salzen
AT366666B (de) Verfahren zur herstellung von neuen amidinosulfon- saeurederivaten und von deren salzen
AT369731B (de) Verfahren zur herstellung von neuen 4-pyridon-3-carbonsaeurederivaten und deren salzen
AT376983B (de) Verfahren zur herstellung von neuen 7-acylaminocephalosporansaeurederivaten und deren salzen
AT372677B (de) Verfahren zur herstellung von neuen basischen oximaethern und von deren saeureadditionssalzen und quaternaeren ammoniumsalzen
AT359507B (de) Verfahren zur herstellung von neuen piperazin- derivaten und deren salzen
AT359481B (de) Verfahren zur herstellung von neuen antiin- flammatorischen 1-phenyl-2-aminoaethanol- derivaten und von deren saeureadditionssalzen
AT360545B (de) Verfahren zur herstellung von neuen piperazin- dithiocarbonsaeurederivaten und deren additions- salzen
ATA238683A (de) Verfahren zur herstellung von neuen eburnan-oxim-aether-derivaten und von deren saeureadditionssalzen
AT375355B (de) Verfahren zur herstellung von neuen phenthiazin-derivaten und von deren salzen
AT373596B (de) Verfahren zur herstellung von neuen piperazinochinazolinderivaten und deren saeureadditionssalzen
AT366665B (de) Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen
ATA144581A (de) Verfahren zur herstellung von neuen phenylessig- saeure-derivaten und deren salzen
AT376438B (de) Verfahren zur herstellung von neuen indolizinderivaten und von deren pharmazeutisch zulaessigen saeureadditionssalzen
ATA112180A (de) Verfahren zur herstellung von neuen guanidin- derivaten und von deren saeureadditionssalzen
ATA144681A (de) Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen
ATA144381A (de) Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen
ATA144781A (de) Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen
ATA333483A (de) Verfahren zur herstellung von neuen indolizinderivaten und deren pharmazeutisch zulaessigen saeureadditionssalzen
ATA333583A (de) Verfahren zur herstellung von neuen indolizinderivaten und deren pharmazeutisch zulaessigen saeureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties